Abstract
Metastasis is responsible for most deaths of cancer burdens. Given that metastatic cancer cells are generally very low in quantity but high in multiplicity, and able to migrate to diverse organs, the diagnosis and intervention of metastatic cancers face varieties of challenges. For example, the biomarker for early diagnosis, and detection of circulating tumor cells by way of epithelial cell adhesion molecule, are complicated by the epithelial-mesenchymal-transition (EMT). Enhanced permeation and retention have been widely explored but with limitations, especially for microscale metastatic tumors. Furthermore, drug-resistance and side-effects of chemotherapy remain problematic for diverse cancers. Interfaces of cells play essential roles in many physiological activities including signal transduction and immunological recognition, which can be exploited for medical application of interfacial materials; indeed, given unique chemical and physical interfacial properties, numerous micro/nano particles and interfacial materials exhibit great potentials for diagnosis and intervention of metastatic cancers. Here we highlight current research, opportunities and challenges for application potentials of biological interfacial engineering in diagnosis and intervention of metastatic cancers.
Keywords: Biological interfacial engineering, cancer, cancer diagnosis and intervention, metastasis.
Current Medicinal Chemistry
Title:Biological Interfacial Engineering for Metastatic Cancer Diagnosis and Intervention
Volume: 21 Issue: 22
Author(s): B. Wang, H. Zhou, Y. Luo, R. Tang and S. Zheng
Affiliation:
Keywords: Biological interfacial engineering, cancer, cancer diagnosis and intervention, metastasis.
Abstract: Metastasis is responsible for most deaths of cancer burdens. Given that metastatic cancer cells are generally very low in quantity but high in multiplicity, and able to migrate to diverse organs, the diagnosis and intervention of metastatic cancers face varieties of challenges. For example, the biomarker for early diagnosis, and detection of circulating tumor cells by way of epithelial cell adhesion molecule, are complicated by the epithelial-mesenchymal-transition (EMT). Enhanced permeation and retention have been widely explored but with limitations, especially for microscale metastatic tumors. Furthermore, drug-resistance and side-effects of chemotherapy remain problematic for diverse cancers. Interfaces of cells play essential roles in many physiological activities including signal transduction and immunological recognition, which can be exploited for medical application of interfacial materials; indeed, given unique chemical and physical interfacial properties, numerous micro/nano particles and interfacial materials exhibit great potentials for diagnosis and intervention of metastatic cancers. Here we highlight current research, opportunities and challenges for application potentials of biological interfacial engineering in diagnosis and intervention of metastatic cancers.
Export Options
About this article
Cite this article as:
Wang B., Zhou H., Luo Y., Tang R. and Zheng S., Biological Interfacial Engineering for Metastatic Cancer Diagnosis and Intervention, Current Medicinal Chemistry 2014; 21 (22) . https://dx.doi.org/10.2174/0929867321666131213102724
DOI https://dx.doi.org/10.2174/0929867321666131213102724 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Shutting Down the Furnace: Preferential Killing of Cancer Cells with Mitochondrial-Targeting Molecules
Current Medicinal Chemistry Bioactive Triterpenic Acids: From Agroforestry Biomass Residues to Promising Therapeutic Tools
Mini-Reviews in Organic Chemistry Protein Targeting Constructs in Alpha Therapy
Current Radiopharmaceuticals The Role of the Endocannabinoid System in Alzheimers Disease: Facts and Hypotheses
Current Pharmaceutical Design 19F: A Versatile Reporter for Non-Invasive Physiology and Pharmacology Using Magnetic Resonance
Current Medicinal Chemistry Advances in Drug Delivery from Nose to Brain: An Overview
Current Drug Therapy Role of mTOR Signaling in Tumor Cell Motility, Invasion and Metastasis
Current Protein & Peptide Science Protein Kinases as Drug Targets in Human and Animal Diseases
Current Enzyme Inhibition Overview of SLC22A and SLCO Families of Drug Uptake Transporters in the Context of Cancer Treatments
Current Drug Metabolism The Renin Angiotensin System in the Regulation of Angiogenesis
Current Pharmaceutical Design DNA Damage-inducing Compounds: Unraveling their Pleiotropic Effects Using High Throughput Sequencing
Current Medicinal Chemistry Resisting the Resistance in Cancer: Cheminformatics Studies on Short- Path Base Excision Repair Pathway Antagonists Using Supervised Learning Approaches
Combinatorial Chemistry & High Throughput Screening The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment
Current Medicinal Chemistry Design, Synthesis and Evaluation of Quinoline-based Small Molecule Inhibitor of STAT3
Letters in Drug Design & Discovery Novel Targeting of Apoptosis Pathways for Prostate Cancer Therapy
Current Cancer Drug Targets Mesenchymal stem cell therapy for inflammatory bowel diseases: promise and challenge
Current Stem Cell Research & Therapy Application of Functional Genomics to Bronchial Asthma
Current Pharmacogenomics Antiinflammatory Activity of Melatonin in Central Nervous System
Current Neuropharmacology Nanobiotechnology-based Drug Delivery in Brain Targeting
Current Pharmaceutical Biotechnology Lipid Metabolism and Mitochondria: Cross Talk in Cancer
Current Drug Targets